AD 6th Oct issue | Page 38

38 HOW TO TREAT : ATRIAL FIBRILLATION

38 HOW TO TREAT : ATRIAL FIBRILLATION

6 OCTOBER 2023 ausdoc . com . au
no further attempts are made to
maintain sinus rhythm . 11
The characteristic findings on a
12-lead ECG are the absence of discernible P waves , and QRS complexes that occur at irregular intervals ( see figure 2 ). Given AF ’ s potential to be paroxysmal , the diagnostic yield is increased with ambulatory monitoring using Holter
Patrick J Lynch / CC BY 2.5 / bit . ly / 3RBDGfs
urgently required in anyone with haemodynamically unstable AF , most patients with AF are haemodynamically stable . A decision then needs to be made regarding whether to pursue rhythm or rate control . A rhythm control strategy involves attempting to convert the patient to sinus rhythm and to maintain this rhythm . On the other hand , a rate control strategy
monitoring ( see figure 3 ), wearable
attempts to bring the heart rate down
devices , smart watches ( see figure 4 ),
to an acceptable target range which is
or implantable loop recorders ( see
less likely to cause symptoms or ven-
figure 5 ). Inpatient cardiac monitor-
tricular dysfunction .
ing ( see figure 6 ) is used in the pres-
The decision to choose rhythm
ence of a TIA and stroke to screen for AF . Longer-term screening for
or rate control is guided by the patient ’ s individual circumstances .
AF with insertable cardiac monitors
While early rhythm control strat-
or non-invasive methods is recom-
egy , instituted within one year of
mended in selected patients , such as
diagnosis , may reduce the risk of
those with embolic stroke of unde-
cardiovascular death and stroke , it
termined source . 12
is associated with a higher rate of
Regular opportunistic screen-
complications related to therapy
ing for AF is recommended for all patients over the age of 65 . 12 This may be performed by pulse pal-
such as drug-induced bradycardia , thyroid disease , QT prolongation , and serious but rare complications
pation screening for an irregular rhythm , followed by an ECG to confirm the diagnosis . 12 The cost-effectiveness of frequent AF screening in
of AF ablation ( for example , pericardial tamponade ). 16 Compelling reasons to pursue rhythm control include patient preference ,
this age group has been confirmed
high ventricular rates refractory to
in multiple analyses . 13
attempted rate control , and unpleas-
Refer those with newly diag-
ant symptoms of AF despite ade-
nosed AF for a transthoracic echo-
quate rate control .
cardiogram , as information on left
atrial size , left ventricular function ,
RATE CONTROL
and the presence of mitral stenosis
Beta blockers , non-dihydropyridine
impacts management . Also inves-
calcium channel blockers ( CCBs ) and
tigate for OSA , which has a strong association with AF . 14 Order electrolytes and thyroid stimulating hor-
digoxin form the backbone of both acute and long-term rate control in AF . Oral beta blockers and non-dihy-
mone if the patient is not acutely
dropyridine CCBs are first-line agents ;
unwell ; AF may be the only mani-
however , their simultaneous use
festation of such abnormalities , and
should be avoided because of the risk
may resolve with appropriate treat-
of complete heart block . Digoxin can
ment of the underlying disorder . 12
be added to either beta blockers or
Routinely screening for CAD in
non-dihydropyridine CCBs for addi-
patients with AF is controversial . It is
tional rate control , or as a standalone
well known that myocardial ischae-
rate control agent if these two agents
mia can trigger AF , that those with AF
are contraindicated , for example ,
have higher rates of subclinical CAD compared with the general popula-
Figure 1 . Left atrial appendage .
because of symptomatic hypotension .
In addition to its role in rhythm
tion , and that the presence of CAD affects the management of AF , given the latter is a contraindication to the
CAD in patients with AF is of benefit . Current guidelines do not make
MANAGEMENT
THE management of AF is multi-
of stroke and management of risk factors .
control , amiodarone can be useful to slow the rate in the acute setting in patients with highly sympto-
use of certain antiarrhythmics , such as flecainide . 15 However , there is no evidence that routine screening for
recommendations regarding routine screening for CAD , beyond performance of a 12-lead ECG
11 , 12
.
pronged and includes choice and enactment of rate or rhythm control , prevention
Rate vs rhythm control
While electrical cardioversion is
matic AF or in those with depressed left ventricular systolic function . A reasonable target is a PAGE 40
Figure 2 . AF on ECG .
Ewingdo / CC BY-SA 4.0 / bit . ly / 3RzYRPd